Related Experiment Video
Updated: Apr 21, 2026
10:39
Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module
Published on: June 18, 2015
12.4K
Curcumin as a protector for normal cells during bortezomib therapy.
1Department of Biophysics, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
Human & Experimental Toxicology
|October 30, 2014
Summary
Curcumin may protect normal cells from bortezomib (Bt) therapy side effects. Co-treatment with curcumin improved erythrocyte δ-aminolevulinic acid dehydratase (ALAD) activity and hemoglobin (Hb) levels in mice.
Area of Science:
- Pharmacology
- Toxicology
- Biochemistry
Background:
- Bortezomib (Bt) is a proteasome inhibitor used in cancer therapy.
- Bt therapy can cause significant side effects on normal cells.
- Curcumin, a compound from turmeric, possesses known therapeutic properties.
Purpose of the Study:
- To evaluate the protective effects of curcumin against bortezomib-induced toxicity in normal cells.
- To investigate the impact of curcumin co-treatment on key biochemical markers affected by bortezomib.
Main Methods:
- Mice were divided into three groups: normal control, bortezomib-treated, and bortezomib + curcumin-treated.
- Erythrocyte δ-aminolevulinic acid dehydratase (ALAD) activity and hemoglobin (Hb) levels were measured.
- Comparative analysis was performed between treatment groups.
Main Results:
- Bortezomib treatment significantly decreased erythrocyte ALAD activity and Hb levels.
- Curcumin co-treatment with bortezomib notably improved ALAD activity and Hb values.
- These findings suggest a mitigating effect of curcumin on bortezomib's adverse impacts.
Conclusions:
- Curcumin co-treatment demonstrates a protective potential against bortezomib-induced side effects on normal cells.
- Curcumin may help preserve normal cellular function during bortezomib therapy.
- Further research is warranted to explore curcumin's therapeutic role in mitigating chemotherapy-related toxicities.
Related Concept Videos
02:57Targeted Cancer Therapies
6.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
6.9K
01:15Drugs that Stabilize Microtubules
2.2K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.2K
02:34Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
01:10Drugs that Destabilize Microtubules
3.1K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
3.1K
02:23Abnormal Proliferation
4.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K